Eisai Inc:企業の戦略的SWOT分析

◆英語タイトル:Eisai Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C12942
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Eisai Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company’s major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemotherapy, Aloxi anti-nausea medication injection, Banzel for adjunctive treatment and Panretin for the treatment of skin lesions in AIDS-related Kaposi’s sarcoma. The company’s research and development activities focus on therapeutic areas such as neuroscience; cancer, antibody-based programs; vascular, inflammatory and immunological reaction. Eisai established partnerships and collaborations with global companies such as Pfizer Inc., Janssen Pharmaceutica Inc., and Elan Pharma International Limited and Elan Pharmaceutical Inc for the development and distribution of drugs. The company is a subsidiary of Eisai Co., Ltd. and is headquartered in New Jersey, the US.

Eisai Inc Key Recent Developments

Sep 06,2018: Oncodesign furthers its cooperation with Eisai, started 12 years ago
Aug 31,2018: XingImaging announces alzheimer’s disease PET imaging in Mainland China
Aug 27,2018: Eisai names Stephen Davies as vice president of its strategic information systems
Aug 27,2018: Stephen Davies appointed Vice President, Eisai strategic information systems at Eisai

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Eisai Inc – Key Facts 5
Eisai Inc – Key Employees 6
Eisai Inc – Key Employee Biographies 7
Eisai Inc – Major Products and Services 8
Eisai Inc – History 9
Eisai Inc – Company Statement 12
Eisai Inc – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Eisai Inc – Business Description 15
Eisai Inc – Corporate Strategy 16
Eisai Inc – SWOT Analysis 17
SWOT Analysis – Overview 17
Eisai Inc – Strengths 17
Eisai Inc – Weaknesses 18
Eisai Inc – Opportunities 19
Eisai Inc – Threats 20
Eisai Inc – Key Competitors 21
Section 3 – Company’s Lifesciences Financial Deals and Alliances 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23
Eisai Inc, Recent Deals Summary 24
Section 4 – Company’s Recent Developments 25
Sep 06, 2018: Oncodesign furthers its cooperation with Eisai, started 12 years ago 25
Aug 31, 2018: XingImaging announces alzheimer’s disease PET imaging in Mainland China 26
Aug 27, 2018: Stephen Davies appointed Vice President, Eisai strategic information systems at Eisai 27
Section 5 – Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Eisai Inc, Key Facts 5
Eisai Inc, Key Employees 6
Eisai Inc, Key Employee Biographies 7
Eisai Inc, Major Products and Services 8
Eisai Inc, History 9
Eisai Inc, Other Locations 13
Eisai Inc, Subsidiaries 13
Eisai Inc, Key Competitors 21
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23
Eisai Inc, Recent Deals Summary 24

List of Figures
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 23

★海外企業調査レポート[Eisai Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CGI Group Inc.:企業の戦略・SWOT・財務情報
    CGI Group Inc. - Strategy, SWOT and Corporate Finance Report Summary CGI Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dollar Tree Inc:企業の戦略・SWOT・財務情報
    Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report Summary Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Eureka Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eureka Therapeutics Inc (Eureka Therapeutics) is a clinical stage biotechnology company which focuses on the development of novel T cell immunotherapies for the treatment of solid tumors. Its pipeline encompasses drug candidates for various indications such as liver cancer, hematological can …
  • B. Braun Melsungen AG:戦略・SWOT・企業財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Semma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Semma Therapeutics Inc (Semma Therapeutics) is a biotechnology company that develops cell replacement therapy for the treatment of diabetes. The company develops therapies using stem cells of the individuals with Type 1 diabetes to produce their own insulin that will regulate the blood sugar …
  • Tainergy Tech Co Ltd (4934):電力:M&Aディール及び事業提携情報
    Summary Tainergy Tech Co Ltd (Tainergy) is a renewable energy company that designs, develops, manufactures and markets solar energy products. The company provides products such as solar deionized water systems, multi-crystalline silicon solar cell, standard solar modules, solar module with build in …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …
  • TeaM Energy Corp:企業の戦略的SWOT分析
    TeaM Energy Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Hearst Corporation:企業の戦略的SWOT分析
    The Hearst Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Luxshare Precision Industry Co., Ltd. (002475):企業の財務・戦略的SWOT分析
    Luxshare Precision Industry Co., Ltd. (002475) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Scottish Power Ltd:企業の発電所・SWOT分析2018
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Cellmid Ltd (CDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Efora Energy Ltd (EEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Efora Energy Ltd (Efora Energy), formerly SacOil Holdings Ltd, a subsidiary of Public Investment Corp Ltd, is an independent oil and gas exploration and production company that acquires, explores, develops and produces hydrocarbon assets in Africa. The company holds a diverse portfolio of as …
  • Biognosys AG-製薬・医療分野:企業M&A・提携分析
    Summary Biognosys AG (Biognosys) is a proteomics company that provides products and services for highly multiplexed protein quantification. The company offers products such as data independent acquisition data analysis software, smartest multiple reaction monitoring and parallel reaction monitoring …
  • OJSC AK BARS Bank:企業の戦略・SWOT・財務情報
    OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report Summary OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ConocoPhillips (COP):電力:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Hinduja Global Solutions Ltd (HGS):企業の財務・戦略的SWOT分析
    Hinduja Global Solutions Ltd (HGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Aeroport Anapa:企業の戦略・SWOT・財務分析
    Aeroport Anapa - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆